Planet Labs vs Roivant Sciences Ltd. Common Shares — how do they compare? Planet Labs trades at $17.35 (market cap $6.25B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4× Planet Labs's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Planet Labs for 4 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| PL | ROIV | |
|---|---|---|
Market Cap | $6.25B | $24.72B |
Volume | 19,125,340 | 6,279,442 |
Sector | Industrials | Health |
52-Week High | $51.40 | $41.81 |
52-Week Low | $11.16 | $16.04 |
Typical Hold Time | 4 Days | 0 Days |
Enterprise Value | $5.89B | $20.99B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →